E-resources
Peer reviewed
Open access
-
Arber, Daniel A; Orazi, Attilio; Hasserjian, Robert P; Borowitz, Michael J; Calvo, Katherine R; Kvasnicka, Hans-Michael; Wang, Sa A; Bagg, Adam; Barbui, Tiziano; Branford, Susan; Bueso-Ramos, Carlos E; Cortes, Jorge E; Dal Cin, Paola; DiNardo, Courtney D; Dombret, Hervé; Duncavage, Eric J; Ebert, Benjamin L; Estey, Elihu H; Facchetti, Fabio; Foucar, Kathryn; Gangat, Naseema; Gianelli, Umberto; Godley, Lucy A; Gökbuget, Nicola; Gotlib, Jason; Hellström-Lindberg, Eva; Hobbs, Gabriela S; Hoffman, Ronald; Jabbour, Elias J; Kiladjian, Jean-Jacques; Larson, Richard A; Le Beau, Michelle M; Loh, Mignon L-C; Löwenberg, Bob; Macintyre, Elizabeth; Malcovati, Luca; Mullighan, Charles G; Niemeyer, Charlotte; Odenike, Olatoyosi M; Ogawa, Seishi; Orfao, Alberto; Papaemmanuil, Elli; Passamonti, Francesco; Porkka, Kimmo; Pui, Ching-Hon; Radich, Jerald P; Reiter, Andreas; Rozman, Maria; Rudelius, Martina; Savona, Michael R; Schiffer, Charles A; Schmitt-Graeff, Annette; Shimamura, Akiko; Sierra, Jorge; Stock, Wendy A; Stone, Richard M; Tallman, Martin S; Thiele, Jürgen; Tien, Hwei-Fang; Tzankov, Alexandar; Vannucchi, Alessandro M; Vyas, Paresh; Wei, Andrew H; Weinberg, Olga K; Wierzbowska, Agnieszka; Cazzola, Mario; Döhner, Hartmut; Tefferi, Ayalew
Blood, 09/2022, Volume: 140, Issue: 11Journal Article
The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collaboration was primarily based on input from a clinical advisory committees (CACs) composed of pathologists, hematologists, oncologists, geneticists, and bioinformaticians from around the world. The recent advances in our understanding of the biology of hematologic malignancies, the experience with the use of the 2016 WHO classification in clinical practice, and the results of clinical trials have indicated the need for further revising and updating the classification. As a continuation of this CAC-based process, the authors, a group with expertise in the clinical, pathologic, and genetic aspects of these disorders, developed the International Consensus Classification (ICC) of myeloid neoplasms and acute leukemias. Using a multiparameter approach, the main objective of the consensus process was the definition of real disease entities, including the introduction of new entities and refined criteria for existing diagnostic categories, based on accumulated data. The ICC is aimed at facilitating diagnosis and prognostication of these neoplasms, improving treatment of affected patients, and allowing the design of innovative clinical trials.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.